FLT3 and acute myeloid leukemia: This study emphasises the potential of NOX as an effective therapeutic target in FLT3-ITD expressing AML, as inhibition and deglycosylation of NOX4 and NOX4D can decrease the levels of H2O2 and DNA damage that would otherwise contribute to genetic instability.